TrialAdvances in therapy2026
Safety, Tolerability and PK Characteristics of RM301B Eye Drops: A Single-Centre, Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial.
Zhishu Bao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.